Variants in ALOX5 , ALOX5AP and LTA4H are not associated with atherosclerotic plaque phenotypes: The Athero-Express Genomics Study

Abstract Background The eicosanoid genes ALOX5 , ALOX5AP and LTA4H have been implicated in atherosclerosis. We assessed the impact of common variants in these genes on gene expression, circulating protein levels, and atherosclerotic plaque phenotypes. Methods We included patients from the Stockholm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 2015-04, Vol.239 (2), p.528-538
Hauptverfasser: van der Laan, Sander W, Foroughi Asl, Hassan, van den Borne, Pleunie, van Setten, Jessica, van der Perk, M.E. Madeleine, van de Weg, Sander M, Schoneveld, Arjan H, de Kleijn, Dominique P.V, Michoel, Tom, Björkegren, Johan L.M, den Ruijter, Hester M, Asselbergs, Folkert W, de Bakker, Paul I.W, Pasterkamp, Gerard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 538
container_issue 2
container_start_page 528
container_title Atherosclerosis
container_volume 239
creator van der Laan, Sander W
Foroughi Asl, Hassan
van den Borne, Pleunie
van Setten, Jessica
van der Perk, M.E. Madeleine
van de Weg, Sander M
Schoneveld, Arjan H
de Kleijn, Dominique P.V
Michoel, Tom
Björkegren, Johan L.M
den Ruijter, Hester M
Asselbergs, Folkert W
de Bakker, Paul I.W
Pasterkamp, Gerard
description Abstract Background The eicosanoid genes ALOX5 , ALOX5AP and LTA4H have been implicated in atherosclerosis. We assessed the impact of common variants in these genes on gene expression, circulating protein levels, and atherosclerotic plaque phenotypes. Methods We included patients from the Stockholm Atherosclerosis Gene Expression study (STAGE, N = 109), and the Athero-Express Biobank Study (AE, N = 1443). We tested 1453 single-nucleotide variants (SNVs) in ALOX5 , ALOX5AP and LTA4H for association with gene expression in STAGE. We also tested these SNVs for association with seven histologically defined plaque phenotypes in the AE (which included calcification, collagen, cellular content, atheroma size, and intraplaque vessel density and hemorrhage). Results We replicate a known cis -eQTL (rs6538697, p = 1.96 × 10−6 ) for LTA4H expression in whole blood of patients from STAGE. We found no significant association for any of the SNVs tested with serum levels of ALOX5 or ALOX5AP (p > 5.79 × 10−4 ). For atherosclerotic plaque phenotypes the strongest associations were found for intraplaque vessel density and smooth muscle cells in the ALOX5AP locus (p > 1.67 × 10−4 ). Conclusions We replicate a known eQTL for LTA4H expression in whole blood using STAGE data. We found no associations of variants in and around ALOX5 , ALOX5AP and LTA4H with serum ALOX5 or ALOX5AP levels, or plaque phenotypes. On the supposition that these genes play a causal role in atherosclerosis, these results suggest that common variants in these loci play a limited role (if any) in influencing advanced atherosclerotic plaque morphology to the extent that it impacts atherosclerotic disease.
doi_str_mv 10.1016/j.atherosclerosis.2015.01.018
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_515382</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0021915015000520</els_id><sourcerecordid>1664206955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-ffb781d02ac42844df6c6b3f9823f79e59ba7125cae9d615fb48fbf69128dc623</originalsourceid><addsrcrecordid>eNqNklGL1DAQx4Mo3nr6FSQvgg92TbJJmwoK5Tj3hIUTbhXfQppM2ex125qknvvqJze16yH3JAyZkPxmJpn_IPSKkiUlNH-7X-q4A98H006rC0tGqFgSmkw-QgsqizKjXPLHaEEIo1lJBTlDz0LYE0J4QeVTdMZEwWhB-AL9-qq9010M2HW42lx_E_jN7KvPWHcWb7YVv8LaA-76iHUIvXE6gsV3Lu7wv2-JzuCh1d9HwMMOEn0cILzD2x3g6g-WXf4cPISA1-n24EzAN3G0x-foSaPbAC9O_hx9-Xi5vbjKNtfrTxfVJjNcspg1TV1IagnThjPJuW1yk9erppRs1RQliLLWBWXCaChtTkVTc9nUTV5SJq3J2eocZXPecAfDWKvBu4P2R9Vrp05Ht2kHSlCxkhP_euYH36dPhagOLhhoW91BPwZF85wzkpdCJPT9jJrUjOChuU9OiZpkU3v1QDY1yaYITSZT_MtTqbE-gL2P_qtTAtYzAKlBPxx4FYyDzoB1HkxUtnf_XerDg0ymdZ0zur2FI4R9P_ouqaCoCkwRdTPN0DRCyQgRjKx-A3DPyKc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664206955</pqid></control><display><type>article</type><title>Variants in ALOX5 , ALOX5AP and LTA4H are not associated with atherosclerotic plaque phenotypes: The Athero-Express Genomics Study</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>van der Laan, Sander W ; Foroughi Asl, Hassan ; van den Borne, Pleunie ; van Setten, Jessica ; van der Perk, M.E. Madeleine ; van de Weg, Sander M ; Schoneveld, Arjan H ; de Kleijn, Dominique P.V ; Michoel, Tom ; Björkegren, Johan L.M ; den Ruijter, Hester M ; Asselbergs, Folkert W ; de Bakker, Paul I.W ; Pasterkamp, Gerard</creator><creatorcontrib>van der Laan, Sander W ; Foroughi Asl, Hassan ; van den Borne, Pleunie ; van Setten, Jessica ; van der Perk, M.E. Madeleine ; van de Weg, Sander M ; Schoneveld, Arjan H ; de Kleijn, Dominique P.V ; Michoel, Tom ; Björkegren, Johan L.M ; den Ruijter, Hester M ; Asselbergs, Folkert W ; de Bakker, Paul I.W ; Pasterkamp, Gerard</creatorcontrib><description>Abstract Background The eicosanoid genes ALOX5 , ALOX5AP and LTA4H have been implicated in atherosclerosis. We assessed the impact of common variants in these genes on gene expression, circulating protein levels, and atherosclerotic plaque phenotypes. Methods We included patients from the Stockholm Atherosclerosis Gene Expression study (STAGE, N = 109), and the Athero-Express Biobank Study (AE, N = 1443). We tested 1453 single-nucleotide variants (SNVs) in ALOX5 , ALOX5AP and LTA4H for association with gene expression in STAGE. We also tested these SNVs for association with seven histologically defined plaque phenotypes in the AE (which included calcification, collagen, cellular content, atheroma size, and intraplaque vessel density and hemorrhage). Results We replicate a known cis -eQTL (rs6538697, p = 1.96 × 10−6 ) for LTA4H expression in whole blood of patients from STAGE. We found no significant association for any of the SNVs tested with serum levels of ALOX5 or ALOX5AP (p &gt; 5.79 × 10−4 ). For atherosclerotic plaque phenotypes the strongest associations were found for intraplaque vessel density and smooth muscle cells in the ALOX5AP locus (p &gt; 1.67 × 10−4 ). Conclusions We replicate a known eQTL for LTA4H expression in whole blood using STAGE data. We found no associations of variants in and around ALOX5 , ALOX5AP and LTA4H with serum ALOX5 or ALOX5AP levels, or plaque phenotypes. On the supposition that these genes play a causal role in atherosclerosis, these results suggest that common variants in these loci play a limited role (if any) in influencing advanced atherosclerotic plaque morphology to the extent that it impacts atherosclerotic disease.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2015.01.018</identifier><identifier>PMID: 25721704</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>5-Lipoxygenase-Activating Proteins - genetics ; Aged ; ALOX5 ; Arachidonate 5-Lipoxygenase - genetics ; Atherosclerosis ; Atherosclerosis - diagnosis ; Atherosclerosis - enzymology ; Atherosclerosis - genetics ; Biological Specimen Banks ; Cardiovascular ; Carotid Artery Diseases - diagnosis ; Carotid Artery Diseases - enzymology ; Carotid Artery Diseases - genetics ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - enzymology ; Coronary Artery Disease - genetics ; Eicosanoids ; Epoxide Hydrolases - genetics ; Female ; Femoral Artery - enzymology ; Femoral Artery - pathology ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Genomics - methods ; Humans ; Male ; Middle Aged ; Netherlands ; Phenotype ; Plaque ; Plaque, Atherosclerotic ; Polymorphism, Single Nucleotide ; Quantitative Trait Loci ; Single-nucleotide polymorphism ; Sweden</subject><ispartof>Atherosclerosis, 2015-04, Vol.239 (2), p.528-538</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2015 Elsevier Ireland Ltd</rights><rights>Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-ffb781d02ac42844df6c6b3f9823f79e59ba7125cae9d615fb48fbf69128dc623</citedby><cites>FETCH-LOGICAL-c482t-ffb781d02ac42844df6c6b3f9823f79e59ba7125cae9d615fb48fbf69128dc623</cites><orcidid>0000-0001-6888-1404</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.atherosclerosis.2015.01.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25721704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:130895592$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>van der Laan, Sander W</creatorcontrib><creatorcontrib>Foroughi Asl, Hassan</creatorcontrib><creatorcontrib>van den Borne, Pleunie</creatorcontrib><creatorcontrib>van Setten, Jessica</creatorcontrib><creatorcontrib>van der Perk, M.E. Madeleine</creatorcontrib><creatorcontrib>van de Weg, Sander M</creatorcontrib><creatorcontrib>Schoneveld, Arjan H</creatorcontrib><creatorcontrib>de Kleijn, Dominique P.V</creatorcontrib><creatorcontrib>Michoel, Tom</creatorcontrib><creatorcontrib>Björkegren, Johan L.M</creatorcontrib><creatorcontrib>den Ruijter, Hester M</creatorcontrib><creatorcontrib>Asselbergs, Folkert W</creatorcontrib><creatorcontrib>de Bakker, Paul I.W</creatorcontrib><creatorcontrib>Pasterkamp, Gerard</creatorcontrib><title>Variants in ALOX5 , ALOX5AP and LTA4H are not associated with atherosclerotic plaque phenotypes: The Athero-Express Genomics Study</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Abstract Background The eicosanoid genes ALOX5 , ALOX5AP and LTA4H have been implicated in atherosclerosis. We assessed the impact of common variants in these genes on gene expression, circulating protein levels, and atherosclerotic plaque phenotypes. Methods We included patients from the Stockholm Atherosclerosis Gene Expression study (STAGE, N = 109), and the Athero-Express Biobank Study (AE, N = 1443). We tested 1453 single-nucleotide variants (SNVs) in ALOX5 , ALOX5AP and LTA4H for association with gene expression in STAGE. We also tested these SNVs for association with seven histologically defined plaque phenotypes in the AE (which included calcification, collagen, cellular content, atheroma size, and intraplaque vessel density and hemorrhage). Results We replicate a known cis -eQTL (rs6538697, p = 1.96 × 10−6 ) for LTA4H expression in whole blood of patients from STAGE. We found no significant association for any of the SNVs tested with serum levels of ALOX5 or ALOX5AP (p &gt; 5.79 × 10−4 ). For atherosclerotic plaque phenotypes the strongest associations were found for intraplaque vessel density and smooth muscle cells in the ALOX5AP locus (p &gt; 1.67 × 10−4 ). Conclusions We replicate a known eQTL for LTA4H expression in whole blood using STAGE data. We found no associations of variants in and around ALOX5 , ALOX5AP and LTA4H with serum ALOX5 or ALOX5AP levels, or plaque phenotypes. On the supposition that these genes play a causal role in atherosclerosis, these results suggest that common variants in these loci play a limited role (if any) in influencing advanced atherosclerotic plaque morphology to the extent that it impacts atherosclerotic disease.</description><subject>5-Lipoxygenase-Activating Proteins - genetics</subject><subject>Aged</subject><subject>ALOX5</subject><subject>Arachidonate 5-Lipoxygenase - genetics</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis - diagnosis</subject><subject>Atherosclerosis - enzymology</subject><subject>Atherosclerosis - genetics</subject><subject>Biological Specimen Banks</subject><subject>Cardiovascular</subject><subject>Carotid Artery Diseases - diagnosis</subject><subject>Carotid Artery Diseases - enzymology</subject><subject>Carotid Artery Diseases - genetics</subject><subject>Coronary Artery Disease - diagnosis</subject><subject>Coronary Artery Disease - enzymology</subject><subject>Coronary Artery Disease - genetics</subject><subject>Eicosanoids</subject><subject>Epoxide Hydrolases - genetics</subject><subject>Female</subject><subject>Femoral Artery - enzymology</subject><subject>Femoral Artery - pathology</subject><subject>Genetic Predisposition to Disease</subject><subject>Genome-Wide Association Study</subject><subject>Genomics - methods</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Netherlands</subject><subject>Phenotype</subject><subject>Plaque</subject><subject>Plaque, Atherosclerotic</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Quantitative Trait Loci</subject><subject>Single-nucleotide polymorphism</subject><subject>Sweden</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNklGL1DAQx4Mo3nr6FSQvgg92TbJJmwoK5Tj3hIUTbhXfQppM2ex125qknvvqJze16yH3JAyZkPxmJpn_IPSKkiUlNH-7X-q4A98H006rC0tGqFgSmkw-QgsqizKjXPLHaEEIo1lJBTlDz0LYE0J4QeVTdMZEwWhB-AL9-qq9010M2HW42lx_E_jN7KvPWHcWb7YVv8LaA-76iHUIvXE6gsV3Lu7wv2-JzuCh1d9HwMMOEn0cILzD2x3g6g-WXf4cPISA1-n24EzAN3G0x-foSaPbAC9O_hx9-Xi5vbjKNtfrTxfVJjNcspg1TV1IagnThjPJuW1yk9erppRs1RQliLLWBWXCaChtTkVTc9nUTV5SJq3J2eocZXPecAfDWKvBu4P2R9Vrp05Ht2kHSlCxkhP_euYH36dPhagOLhhoW91BPwZF85wzkpdCJPT9jJrUjOChuU9OiZpkU3v1QDY1yaYITSZT_MtTqbE-gL2P_qtTAtYzAKlBPxx4FYyDzoB1HkxUtnf_XerDg0ymdZ0zur2FI4R9P_ouqaCoCkwRdTPN0DRCyQgRjKx-A3DPyKc</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>van der Laan, Sander W</creator><creator>Foroughi Asl, Hassan</creator><creator>van den Borne, Pleunie</creator><creator>van Setten, Jessica</creator><creator>van der Perk, M.E. Madeleine</creator><creator>van de Weg, Sander M</creator><creator>Schoneveld, Arjan H</creator><creator>de Kleijn, Dominique P.V</creator><creator>Michoel, Tom</creator><creator>Björkegren, Johan L.M</creator><creator>den Ruijter, Hester M</creator><creator>Asselbergs, Folkert W</creator><creator>de Bakker, Paul I.W</creator><creator>Pasterkamp, Gerard</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><orcidid>https://orcid.org/0000-0001-6888-1404</orcidid></search><sort><creationdate>20150401</creationdate><title>Variants in ALOX5 , ALOX5AP and LTA4H are not associated with atherosclerotic plaque phenotypes: The Athero-Express Genomics Study</title><author>van der Laan, Sander W ; Foroughi Asl, Hassan ; van den Borne, Pleunie ; van Setten, Jessica ; van der Perk, M.E. Madeleine ; van de Weg, Sander M ; Schoneveld, Arjan H ; de Kleijn, Dominique P.V ; Michoel, Tom ; Björkegren, Johan L.M ; den Ruijter, Hester M ; Asselbergs, Folkert W ; de Bakker, Paul I.W ; Pasterkamp, Gerard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-ffb781d02ac42844df6c6b3f9823f79e59ba7125cae9d615fb48fbf69128dc623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>5-Lipoxygenase-Activating Proteins - genetics</topic><topic>Aged</topic><topic>ALOX5</topic><topic>Arachidonate 5-Lipoxygenase - genetics</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis - diagnosis</topic><topic>Atherosclerosis - enzymology</topic><topic>Atherosclerosis - genetics</topic><topic>Biological Specimen Banks</topic><topic>Cardiovascular</topic><topic>Carotid Artery Diseases - diagnosis</topic><topic>Carotid Artery Diseases - enzymology</topic><topic>Carotid Artery Diseases - genetics</topic><topic>Coronary Artery Disease - diagnosis</topic><topic>Coronary Artery Disease - enzymology</topic><topic>Coronary Artery Disease - genetics</topic><topic>Eicosanoids</topic><topic>Epoxide Hydrolases - genetics</topic><topic>Female</topic><topic>Femoral Artery - enzymology</topic><topic>Femoral Artery - pathology</topic><topic>Genetic Predisposition to Disease</topic><topic>Genome-Wide Association Study</topic><topic>Genomics - methods</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Netherlands</topic><topic>Phenotype</topic><topic>Plaque</topic><topic>Plaque, Atherosclerotic</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Quantitative Trait Loci</topic><topic>Single-nucleotide polymorphism</topic><topic>Sweden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van der Laan, Sander W</creatorcontrib><creatorcontrib>Foroughi Asl, Hassan</creatorcontrib><creatorcontrib>van den Borne, Pleunie</creatorcontrib><creatorcontrib>van Setten, Jessica</creatorcontrib><creatorcontrib>van der Perk, M.E. Madeleine</creatorcontrib><creatorcontrib>van de Weg, Sander M</creatorcontrib><creatorcontrib>Schoneveld, Arjan H</creatorcontrib><creatorcontrib>de Kleijn, Dominique P.V</creatorcontrib><creatorcontrib>Michoel, Tom</creatorcontrib><creatorcontrib>Björkegren, Johan L.M</creatorcontrib><creatorcontrib>den Ruijter, Hester M</creatorcontrib><creatorcontrib>Asselbergs, Folkert W</creatorcontrib><creatorcontrib>de Bakker, Paul I.W</creatorcontrib><creatorcontrib>Pasterkamp, Gerard</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van der Laan, Sander W</au><au>Foroughi Asl, Hassan</au><au>van den Borne, Pleunie</au><au>van Setten, Jessica</au><au>van der Perk, M.E. Madeleine</au><au>van de Weg, Sander M</au><au>Schoneveld, Arjan H</au><au>de Kleijn, Dominique P.V</au><au>Michoel, Tom</au><au>Björkegren, Johan L.M</au><au>den Ruijter, Hester M</au><au>Asselbergs, Folkert W</au><au>de Bakker, Paul I.W</au><au>Pasterkamp, Gerard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variants in ALOX5 , ALOX5AP and LTA4H are not associated with atherosclerotic plaque phenotypes: The Athero-Express Genomics Study</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>239</volume><issue>2</issue><spage>528</spage><epage>538</epage><pages>528-538</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Abstract Background The eicosanoid genes ALOX5 , ALOX5AP and LTA4H have been implicated in atherosclerosis. We assessed the impact of common variants in these genes on gene expression, circulating protein levels, and atherosclerotic plaque phenotypes. Methods We included patients from the Stockholm Atherosclerosis Gene Expression study (STAGE, N = 109), and the Athero-Express Biobank Study (AE, N = 1443). We tested 1453 single-nucleotide variants (SNVs) in ALOX5 , ALOX5AP and LTA4H for association with gene expression in STAGE. We also tested these SNVs for association with seven histologically defined plaque phenotypes in the AE (which included calcification, collagen, cellular content, atheroma size, and intraplaque vessel density and hemorrhage). Results We replicate a known cis -eQTL (rs6538697, p = 1.96 × 10−6 ) for LTA4H expression in whole blood of patients from STAGE. We found no significant association for any of the SNVs tested with serum levels of ALOX5 or ALOX5AP (p &gt; 5.79 × 10−4 ). For atherosclerotic plaque phenotypes the strongest associations were found for intraplaque vessel density and smooth muscle cells in the ALOX5AP locus (p &gt; 1.67 × 10−4 ). Conclusions We replicate a known eQTL for LTA4H expression in whole blood using STAGE data. We found no associations of variants in and around ALOX5 , ALOX5AP and LTA4H with serum ALOX5 or ALOX5AP levels, or plaque phenotypes. On the supposition that these genes play a causal role in atherosclerosis, these results suggest that common variants in these loci play a limited role (if any) in influencing advanced atherosclerotic plaque morphology to the extent that it impacts atherosclerotic disease.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>25721704</pmid><doi>10.1016/j.atherosclerosis.2015.01.018</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6888-1404</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 2015-04, Vol.239 (2), p.528-538
issn 0021-9150
1879-1484
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_515382
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects 5-Lipoxygenase-Activating Proteins - genetics
Aged
ALOX5
Arachidonate 5-Lipoxygenase - genetics
Atherosclerosis
Atherosclerosis - diagnosis
Atherosclerosis - enzymology
Atherosclerosis - genetics
Biological Specimen Banks
Cardiovascular
Carotid Artery Diseases - diagnosis
Carotid Artery Diseases - enzymology
Carotid Artery Diseases - genetics
Coronary Artery Disease - diagnosis
Coronary Artery Disease - enzymology
Coronary Artery Disease - genetics
Eicosanoids
Epoxide Hydrolases - genetics
Female
Femoral Artery - enzymology
Femoral Artery - pathology
Genetic Predisposition to Disease
Genome-Wide Association Study
Genomics - methods
Humans
Male
Middle Aged
Netherlands
Phenotype
Plaque
Plaque, Atherosclerotic
Polymorphism, Single Nucleotide
Quantitative Trait Loci
Single-nucleotide polymorphism
Sweden
title Variants in ALOX5 , ALOX5AP and LTA4H are not associated with atherosclerotic plaque phenotypes: The Athero-Express Genomics Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T18%3A24%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variants%20in%20ALOX5%20,%20ALOX5AP%20and%20LTA4H%20are%20not%20associated%20with%20atherosclerotic%20plaque%20phenotypes:%20The%20Athero-Express%20Genomics%20Study&rft.jtitle=Atherosclerosis&rft.au=van%20der%20Laan,%20Sander%20W&rft.date=2015-04-01&rft.volume=239&rft.issue=2&rft.spage=528&rft.epage=538&rft.pages=528-538&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2015.01.018&rft_dat=%3Cproquest_swepu%3E1664206955%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1664206955&rft_id=info:pmid/25721704&rft_els_id=1_s2_0_S0021915015000520&rfr_iscdi=true